BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Nov 18, 2025; 16(11): 112198
Published online Nov 18, 2025. doi: 10.5312/wjo.v16.i11.112198
Shoulder complications in sickle cell disease: Challenges, management strategies, and future directions
Emad Anam
Emad Anam, Department of Orthopedic Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah 33335, Saudi Arabia
Author contributions: Anam E designed, organized, and wrote the manuscript. Also, the author is responsible for the content and the integrity of this review.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Emad Anam, Assistant Professor, FRCS, Department of Orthopedic Surgery, Faculty of Medicine, King Abdulaziz University, 7053 Alfyha District, Jeddah 33335, Saudi Arabia. em2009@hotmail.com
Received: July 21, 2025
Revised: August 21, 2025
Accepted: October 24, 2025
Published online: November 18, 2025
Processing time: 116 Days and 22.3 Hours
Core Tip

Core Tip: This comprehensive narrative review highlights the challenges of managing shoulder complications in sickle cell disease (SCD) which discusses a critical and underexplored part of this disease. The review synthesizes current evidence on the three primary complications avascular necrosis, osteomyelitis, and septic arthritis. SCD leads to chronic hemolysis and vaso-occlousive crisis contribute to ischemic damage, with humeral head avascular necrosis often underdiagnosed due to overlapping symptoms with other conditions. Early diagnosis and differentiation rely on advanced imaging and laboratory tests. Management includes pain control, core decompression for early stages, and arthroplasty for advanced cases. Given the scarcity of research on shoulder pathology in SCD, larger, long-term studies are needed to refine treatment strategies and improve patient outcomes.